Inflammatory Biomarkers and Risk of Psychiatric Disorders
Yu Zeng(Sichuan University), Dang Wei(Harvard University), Christina Seitz(Karolinska Institutet), Unnur Valdimarsdóttir(Harvard University), Niklas Hammar(Karolinska Institutet), Fang Fang(Jinshan Hospital of Fudan University), Huan Song(University of Iceland), Charilaos Chourpiliadis(Karolinska Institutet)
Cited by 89
Related Papers
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
|Journal of the American College of Cardiology|2018|465
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
|Journal of Clinical Oncology|2009|245
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
|Journal of Clinical Oncology|2010|217
Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders
|JAMA Network Open|2024|139
Mediterranean diet and depression: a population-based cohort study
|International Journal of Behavioral Nutrition and Physical Activity|2021|138